Current Report · Items 7.01, 9.01 · 8-K

Rafael Holdings, Inc.

RFLNYSEEQUITYCurrent

Regulation FD Disclosure

Filed Jul 8, 2026Accepted Jul 8, 2026, 4:45 PM EDTCIK 1713863Accession 0001213900-26-076411

Company context

Rafael Holdings, Inc. is a biotechnology company that develops pharmaceuticals and holds interests in clinical and early-stage companies that develop pharmaceuticals and medical devices. Our lead candidate is Trappsol® Cyclo™, and we have completed a pivotal Phase 3 study in NPC and are preparing for a planned NDA submission later this year. Niemann-Pick Disease Type C (“NPC”) is a rare, fatal and progressive genetic disorder. We also hold interests in other clinical-stage and early-stage pharmaceutical development companies and an orthopedic-focused medical device company.

Current securities

RFLNYSE · EQUITY · Current

Historical securities (1)

RFL.WSNYSE · WARRANT · Historical · closed Dec 11, 2025

Recent company filings

Disclosure sections

Items 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 7.01Item 7.01 - Regulation FD Disclosure

Item 7.01. Regulation FD From July 8, 2026, the slide presentation (the “Presentation”) attached hereto as Exhibit 99.1 will be available on the Registrant’s website at the following link: https://rafaelholdings.irpass.com/. The Registrant is furnishing the information contained in this Report, including Exhibit 99.1, pursuant to Item 7.01 of Form 8-K promulgated by the Securities and Exchange Commission (the “SEC”). This information shall not be deemed to be “filed” with the SEC or incorporated by reference into any other filing with the SEC. In addition, the Presentation contains statements intended as “forward-looking statements” that are subject to the cautionary statements about forward-looking statements set forth in the Presentation. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Document 99.1 Investor Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

Filed exhibits (1)

EX-99.1 (by filename) ea029744201ex99-1.htm

EX-99.1 2 ea029744201ex99-1.htm INVESTOR PRESENTATION Exhibit 99.1 NYSE: RFL July 2026 | Investor Presentation Forward-Looking Statements Some of the information in this presentation relates to future events or future business and financial performance. Such statements constitute forward-looking information within the meaning of the Private Securities Litigation Act of 1995. Such statements can be only predictions and the actual events or results may differ from those discussed due to, among other things, the risks described in the public filings and other publications of Rafael Holdings, Inc. Forward-looking statements are identified by words such as "anticipates", "projects", "expects", "plans", "intends", "believes", "estimates", "target", and other similar expressions that indicate trends and future events. The market data and certain other statistical information used throughout this presentation are based on independent industry publications, governmental publications, reports by market research firms or other independent sources. Some data are also based on the Company's good faith estimates. In addition, this presentation includes summaries of scientific activities an…

Open exhibit ↗

Get the free weekly BCS email.